Does the media prefer TMO or ANGO?

In the previous week, Thermo Fisher Scientific had 25 more articles in the media than AngioDynamics. MarketBeat recorded 27 mentions for Thermo Fisher Scientific and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.52 beat Thermo Fisher Scientific's score of 1.50 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 25 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor ANGO or WST?

In the previous week, West Pharmaceutical Services had 6 more articles in the media than AngioDynamics. MarketBeat recorded 8 mentions for West Pharmaceutical Services and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.52 beat West Pharmaceutical Services' score of 0.73 indicating that AngioDynamics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive West Pharmaceutical Services 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SMA or ANGO?

In the previous week, Smartstop Self Storage REIT and Smartstop Self Storage REIT both had 2 articles in the media. AngioDynamics' average media sentiment score of 1.52 beat Smartstop Self Storage REIT's score of 0.61 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smartstop Self Storage REIT 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings and valuation, ATRC or ANGO?

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 2.66 -$11.45M -$0.10 N/A AngioDynamics $292.50M 1.93 -$33.99M -$0.75 N/A

Is ATRC or ANGO more profitable?

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -10.01%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity. Company Net Margins Return on Equity Return on Assets AtriCure -0.83% 0.29% 0.22% AngioDynamics -10.01% -4.66% -3.08%

Does the media refer more to ATRC or ANGO?

In the previous week, AtriCure and AtriCure both had 2 articles in the media. AngioDynamics' average media sentiment score of 1.52 beat AtriCure's score of 0.96 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to IART or ANGO?

In the previous week, Integra LifeSciences had 3 more articles in the media than AngioDynamics. MarketBeat recorded 5 mentions for Integra LifeSciences and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.52 beat Integra LifeSciences' score of 0.66 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

AngioDynamics (ANGO) Competitors

$13.66 +0.71 (+5.48%)

Closing price 06/25/2026 04:00 PM Eastern

Extended Trading

$13.66 -0.01 (-0.04%)

As of 04:40 AM Eastern

Compare

ANGO vs. TMO, WST, SMA, ATRC, and IART

Should you buy AngioDynamics stock or one of its competitors? MarketBeat compares AngioDynamics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), and Integra LifeSciences (IART).

How does AngioDynamics compare to Thermo Fisher Scientific?

Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	4.22	$6.70B	$18.19	27.83
AngioDynamics	$292.50M	1.93	-$33.99M	-$0.75	N/A

Thermo Fisher Scientific has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Thermo Fisher Scientific presently has a consensus target price of $608.95, indicating a potential upside of 20.30%. AngioDynamics has a consensus target price of $18.67, indicating a potential upside of 36.65%. Given AngioDynamics' higher possible upside, analysts clearly believe AngioDynamics is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	5 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.88
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Thermo Fisher Scientific has a net margin of 15.15% compared to AngioDynamics' net margin of -10.01%. Thermo Fisher Scientific's return on equity of 16.86% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.15%	16.86%	8.15%
AngioDynamics	-10.01%	-4.66%	-3.08%

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by insiders. Comparatively, 6.0% of AngioDynamics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Thermo Fisher Scientific had 25 more articles in the media than AngioDynamics. MarketBeat recorded 27 mentions for Thermo Fisher Scientific and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.52 beat Thermo Fisher Scientific's score of 1.50 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	25 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Thermo Fisher Scientific beats AngioDynamics on 13 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to West Pharmaceutical Services?

AngioDynamics (NASDAQ:ANGO) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

West Pharmaceutical Services has a net margin of 16.85% compared to AngioDynamics' net margin of -10.01%. West Pharmaceutical Services' return on equity of 19.03% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-10.01%	-4.66%	-3.08%
West Pharmaceutical Services	16.85%	19.03%	14.06%

AngioDynamics currently has a consensus price target of $18.67, indicating a potential upside of 36.65%. West Pharmaceutical Services has a consensus price target of $340.09, indicating a potential downside of 2.09%. Given AngioDynamics' higher probable upside, equities research analysts clearly believe AngioDynamics is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	3.00

In the previous week, West Pharmaceutical Services had 6 more articles in the media than AngioDynamics. MarketBeat recorded 8 mentions for West Pharmaceutical Services and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.52 beat West Pharmaceutical Services' score of 0.73 indicating that AngioDynamics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
West Pharmaceutical Services	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 6.0% of AngioDynamics shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

AngioDynamics has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

West Pharmaceutical Services has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$292.50M	1.93	-$33.99M	-$0.75	N/A
West Pharmaceutical Services	$3.07B	7.98	$493.70M	$7.48	46.44

Summary

West Pharmaceutical Services beats AngioDynamics on 14 of the 17 factors compared between the two stocks.

How does AngioDynamics compare to Smartstop Self Storage REIT?

Smartstop Self Storage REIT (NYSE:SMA) and AngioDynamics (NASDAQ:ANGO) are both small-cap health care equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Smartstop Self Storage REIT has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

Smartstop Self Storage REIT presently has a consensus target price of $36.81, suggesting a potential upside of 12.60%. AngioDynamics has a consensus target price of $18.67, suggesting a potential upside of 36.65%. Given AngioDynamics' higher possible upside, analysts plainly believe AngioDynamics is more favorable than Smartstop Self Storage REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.70
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

89.4% of AngioDynamics shares are owned by institutional investors. 5.5% of Smartstop Self Storage REIT shares are owned by insiders. Comparatively, 6.0% of AngioDynamics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Smartstop Self Storage REIT has a net margin of 4.38% compared to AngioDynamics' net margin of -10.01%. Smartstop Self Storage REIT's return on equity of 1.00% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smartstop Self Storage REIT	4.38%	1.00%	0.54%
AngioDynamics	-10.01%	-4.66%	-3.08%

In the previous week, Smartstop Self Storage REIT and Smartstop Self Storage REIT both had 2 articles in the media. AngioDynamics' average media sentiment score of 1.52 beat Smartstop Self Storage REIT's score of 0.61 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smartstop Self Storage REIT	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Smartstop Self Storage REIT has higher earnings, but lower revenue than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smartstop Self Storage REIT	$281.14M	6.44	-$1.55M	$0.15	217.95
AngioDynamics	$292.50M	1.93	-$33.99M	-$0.75	N/A

Summary

Smartstop Self Storage REIT beats AngioDynamics on 11 of the 16 factors compared between the two stocks.

How does AngioDynamics compare to AtriCure?

AtriCure (NASDAQ:ATRC) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

AtriCure currently has a consensus price target of $48.71, suggesting a potential upside of 73.18%. AngioDynamics has a consensus price target of $18.67, suggesting a potential upside of 36.65%. Given AtriCure's higher possible upside, equities research analysts plainly believe AtriCure is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, AtriCure and AtriCure both had 2 articles in the media. AngioDynamics' average media sentiment score of 1.52 beat AtriCure's score of 0.96 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

AtriCure has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market.

AtriCure has higher revenue and earnings than AngioDynamics. AtriCure is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	2.66	-$11.45M	-$0.10	N/A
AngioDynamics	$292.50M	1.93	-$33.99M	-$0.75	N/A

AtriCure has a net margin of -0.83% compared to AngioDynamics' net margin of -10.01%. AtriCure's return on equity of 0.29% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
AngioDynamics	-10.01%	-4.66%	-3.08%

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 4.0% of AtriCure shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

AtriCure beats AngioDynamics on 11 of the 15 factors compared between the two stocks.

How does AngioDynamics compare to Integra LifeSciences?

Integra LifeSciences (NASDAQ:IART) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

AngioDynamics has lower revenue, but higher earnings than Integra LifeSciences. AngioDynamics is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.86	-$516.47M	-$6.46	N/A
AngioDynamics	$292.50M	1.93	-$33.99M	-$0.75	N/A

AngioDynamics has a net margin of -10.01% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
AngioDynamics	-10.01%	-4.66%	-3.08%

Integra LifeSciences has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Integra LifeSciences currently has a consensus price target of $16.20, indicating a potential downside of 10.50%. AngioDynamics has a consensus price target of $18.67, indicating a potential upside of 36.65%. Given AngioDynamics' stronger consensus rating and higher possible upside, analysts clearly believe AngioDynamics is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Integra LifeSciences had 3 more articles in the media than AngioDynamics. MarketBeat recorded 5 mentions for Integra LifeSciences and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.52 beat Integra LifeSciences' score of 0.66 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

AngioDynamics beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

Get AngioDynamics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ANGO vs. The Competition

Export

Metric	AngioDynamics	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$535.08M	$7.27B	$6.61B	$12.27B
Dividend Yield	N/A	1.27%	2.67%	5.89%
P/E Ratio	-18.21	49.62	25.77	23.97
Price / Sales	1.93	47.51	544.12	99.70
Price / Cash	26.59	25.66	46.33	53.91
Price / Book	3.03	7.40	10.53	6.32
Net Income	-$33.99M	$159.20M	$3.57B	$337.22M
7 Day Performance	12.43%	0.82%	0.77%	-1.24%
1 Month Performance	15.76%	0.44%	0.19%	-0.63%
1 Year Performance	38.40%	5.87%	30.81%	27.95%

AngioDynamics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ANGO AngioDynamics	4.0129 of 5 stars	$13.66 +5.5%	$18.67 +36.7%	+33.8%	$535.08M	$292.50M	N/A	760	Positive News
TMO Thermo Fisher Scientific	4.9052 of 5 stars	$474.01 +0.1%	$608.95 +28.5%	+23.3%	$176.75B	$44.56B	26.15	125,000	Trending News
WST West Pharmaceutical Services	3.7082 of 5 stars	$329.62 -0.5%	$340.09 +3.2%	+57.1%	$23.44B	$3.07B	44.36	10,800
SMA Smartstop Self Storage REIT	3.1801 of 5 stars	$32.37 +0.4%	$36.81 +13.7%	-12.1%	$1.79B	$281.14M	215.25	N/A
ATRC AtriCure	3.5986 of 5 stars	$28.07 +0.3%	$48.71 +73.6%	-12.8%	$1.42B	$534.53M	N/A	1,300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ANGO) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and IART

How does AngioDynamics compare to Thermo Fisher Scientific?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Summary

How does AngioDynamics compare to AtriCure?

Summary

How does AngioDynamics compare to Integra LifeSciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AngioDynamics (ANGO) Competitors

ANGO vs. TMO, WST, SMA, ATRC, and IART

How does AngioDynamics compare to Thermo Fisher Scientific?

Which has better earnings & valuation, TMO or ANGO?

Which has more risk & volatility, TMO or ANGO?

Do analysts rate TMO or ANGO?

Is TMO or ANGO more profitable?

Do insiders and institutionals believe in TMO or ANGO?

Does the media prefer TMO or ANGO?

Summary

How does AngioDynamics compare to West Pharmaceutical Services?

Is ANGO or WST more profitable?

Do analysts prefer ANGO or WST?

Does the media favor ANGO or WST?

Do insiders & institutionals hold more shares of ANGO or WST?

Which has more risk & volatility, ANGO or WST?

Which has stronger earnings and valuation, ANGO or WST?

Summary

How does AngioDynamics compare to Smartstop Self Storage REIT?

Which has more volatility and risk, SMA or ANGO?

Do analysts prefer SMA or ANGO?

Do insiders & institutionals hold more shares of SMA or ANGO?

Is SMA or ANGO more profitable?

Does the media prefer SMA or ANGO?

Which has stronger valuation and earnings, SMA or ANGO?

Summary

How does AngioDynamics compare to AtriCure?

Do analysts recommend ATRC or ANGO?

Does the media refer more to ATRC or ANGO?

Which has more volatility and risk, ATRC or ANGO?

Which has stronger earnings and valuation, ATRC or ANGO?

Is ATRC or ANGO more profitable?

Do institutionals and insiders have more ownership in ATRC or ANGO?

Summary

How does AngioDynamics compare to Integra LifeSciences?

Which has better earnings & valuation, IART or ANGO?

Is IART or ANGO more profitable?

Which has more volatility & risk, IART or ANGO?

Do analysts prefer IART or ANGO?

Do insiders & institutionals have more ownership in IART or ANGO?

Does the media refer more to IART or ANGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGO vs. The Competition

AngioDynamics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools